Companies /Basic Materials

Ecolab Inc

NYSE: ECL Specialty Chemicals
$278.11
▼ $1.17 (−0.42%) today
Markets closed · 8:34pm ET

Q3 2025 Earnings

Reported Oct 28, 2025, 8:10am ET · SEC source
$2.07
Miss −0.09%
EPS · est. $2.07
$4.2B
Beat +1.07%
Revenue · est. $4.1B
+3.1%
Beating market
ECL vs S&P since report
3 quarters
Consecutive EPS beats

Market Reaction

% change · around the report
−6%−4%−2%0Oct 28Oct 29report 8:10am ETearnings+0.3%−6.3%
−6%−4%−2%0Oct 28Oct 29earnings+0.3%−6.3%
ECL −6.3%S&P 500 +0.3%
−6%−3%0Oct 28Oct 29report 8:10am ETearnings+1.0%−6.3%
−6%−3%0Oct 28Oct 29earnings+1.0%−6.3%
ECL −6.3%NASDAQ +1.0%
−9%−6%−3%0Oct 27Nov 4report 8:10am ETearnings−1.5%−7.5%
−9%−6%−3%0Oct 27Nov 4earnings−1.5%−7.5%
ECL −7.5%S&P 500 −1.5%
−8%−4%0Oct 27Nov 4report 8:10am ETearnings−1.5%−7.5%
−8%−4%0Oct 27Nov 4earnings−1.5%−7.5%
ECL −7.5%NASDAQ −1.5%
−4.09%
Day of report
−4.03%
Next session
−3.59%
One week
+2.56%
30 days

S&P 500 over the same 30 days: −0.53%.

Did ECL Beat Earnings? Q3 2025 Results

Ecolab posted a broadly solid third quarter for fiscal 2025, with revenue clearing expectations even as adjusted earnings came in just a hair below the consensus. The water, hygiene, and infection prevention giant reported Q3 revenue of $4.17 billion, up 4.2% year-over-year and ahead of the $4.12 billion analysts had forecast, while adjusted diluted EPS of $2.07 landed fractionally below the $2.07 consensus estimate, a miss of just 0.09%. The headline earnings comparison looked stark on a reported basis, as the prior-year period included a $364 million gain from the divestiture of the global surgical solutions business, but the underlying story was one of consistent execution: organic sales grew 3%, driven by accelerating value pricing and steady volume gains, while organic operating income margin expanded 110 basis points to 18.7%. Growth engines including Life Sciences, Pest Elimination, and Ecolab Digital, which grew sales 25% to $96 million, continued to lead. Despite a post-earnings share pullback, management tightened full-year 2025 adjusted EPS guidance to $7.48 to $7.58, representing 12% to 14% growth, and expressed confidence in sustaining 12% to 15% EPS growth into 2026.

Key Takeaways
  • Value pricing accelerating from 2% to 3%
  • Continued 1% volume growth driven by new business wins and breakthrough innovation
  • Strong organic operating income margin expansion of 110 bps to 18.7%
  • Growth engines (Life Sciences, Pest Elimination, Global High-Tech, Ecolab Digital) collectively grew double digits
  • Improved supply chain operations and productivity
  • One Ecolab enterprise growth strategy driving cross-selling

“Our team once again delivered a strong and consistent quarter of double-digit earnings growth, driven by value pricing accelerating from 2% to 3%, volume growth of 1%, and strong operating income margin expansion. Ecolab's growth engines, which include Life Sciences, Pest Elimination, Global High-Tech and Ecolab Digital, collectively grew double digits. Performance in our core businesses was led by mid-single digit growth in Institutional & Specialty and accelerating Food & Beverage growth, as we leveraged our breakthrough innovations and the power of our One Ecolab enterprise growth strategy.”

Ecolab CEO, on the earnings call

Forward Guidance & Outlook

Ecolab sharpened its full-year 2025 adjusted diluted EPS guidance to $7.48–$7.58, representing 12%–14% growth versus 2024's $6.65. Fourth quarter 2025 adjusted diluted EPS is expected in the $2.02–$2.12 range, up 12%–17% year-over-year. Management expressed confidence in delivering 12%–15% EPS growth in 2026 beginning in Q1. Secular growth trends in water, hygiene, infection prevention, and digital technologies continue to fuel long-term demand. Near-term risks include unpredictable geopolitics and evolving trade policy impacting end-market demand. The company expects approximately $0.34 per share of special charges in 2025 related to restructuring.

ECL YoY Financials

Q3 2025 vs Q3 2024 · SEC filings Q3 2024 Q3 2025
$0$2.0B$4.0B$4.0B$4.2BRevenue$1.7B$1.9BGross Profit$707.2M$760.2MOperating Income$736.5M$585.0MNet Income
$0$2.0B$4.0BRevenueGross ProfitOperating IncomeNet Income

ECL Revenue by Segment

Global Water$2.1B+4.0%
Global Institutional & Specialty$1.6B+2.0%
Global Pest Elimination$331.8M+8.0%
Global Life Sciences$184.7M+10.0%
Ecolab Digital$96.0M+25.0%

Figures from SEC filings and company reports. Not investment advice.